In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
Liquid Vitamins vs. Pills: Which Works Better for Women?
Home Blog > Liquid Vitamins vs. Pills: Which Works Better for Women? Table of Contents Liquid…
7 Things Employers Should Be Doing to Fulfill Their Fiduciary Duty
Analyzing medical claims data is essential to fulfilling a self-funded employer’s fiduciary duty, which is to…
Research Finds This Dysfunction Could Be Fueling Alzheimer’s Risk
Alzheimer’s disease impacts millions of people around the world, including at least 7 million in the…
Duke Spinout Launches Platform to Unite Care and Clinical Research
People across the nation continue to struggle with basic healthcare access, with nearly a third of…
The Major Skin Care Benefits Of Blood Orange Extract*
The beauty industry is regularly turning to the botanical world for solutions, both internal and external….
Eat These Foods To Lower Your Dementia Risk By Up To 17%, Study Says
In recent years, evidence has been mounting that lifestyle factors, including nutrition, exercise, sleep, and stress,…
